Activation of epidermal melanocytes depends on epithelial proliferation and vascularization. Immunohistologic evaluation with HMB-45 antibody and literature review;Aktivierung epidermaler melanozyten ist abhangig von epithelialer Proliferation und Vaskularisierung. Immunhistologische Studie unter Verwendung des HMB-45-Antikorpers mit Literaturubersicht

Hautarzt

Volumn 47, Issue 8, 1996, Pages 616-623

  Lommel, Kerstin ^a   Tronnier, Michael ^a   Wolff, Helmut H ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

double staining technique; HMB 45; immunohistochemistry; melanocytic activation

Indexed keywords

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOCYTE; SKIN TUMOR; BIOPSY; CELL DIVISION; DIFFERENTIAL DIAGNOSIS; ENZYME IMMUNOASSAY; MELANOMA; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; REVIEW; SKIN; SKIN DISEASE; VASCULARIZATION;

MELANOMA SPECIFIC ANTIGENS; MELANOMA-SPECIFIC ANTIGENS; TUMOR MARKER; TUMOR PROTEIN;

BIOPSY; CELL DIVISION; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOENZYME TECHNIQUES; MELANOCYTES; MELANOMA; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; SKIN; SKIN DISEASES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029779550     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050478     Document Type: Article

References (65)

1. Ahmed I, Piepkorn M, Goldgar DE, Cannon-Albright LA, Meyer JL, Skolnick MH, Zone JJ (1991) HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups. J Cutan Pathol 18:257-260
2. Ashfaq R, Weinberg AG, Albores-Saavedra J (1993) Renal angiomyolipomas and HMB-45 reactivity. Cancer 71:3091-3097
3. Azumi M, Battifora H (1987) The distribution of Vimentin and keratin in epithelial and nonepithelia neoplasms. J Clin Pathol 88:286-296
4. Battifora H (1991) Assessment of antigen damage in immunohistochemistry. Am J Clin Pathol 96:669-671
5. Bonetti F, Colombari R, Manfrin E, Zamboni G, Martignoni G, Mombello A, Chilosi M (1989) Breast carcinoma with positive results for melanoma marker (HMB-45). Am J Clin Pathol 92:491-495
6. Bonetti F, Pea M, Martignoni G, Mombello A, Colombari R, Zamboni G, Scarpa A, Piubello Q, Bacchi CE, Gown AM (1991) False-positive immunostaining of normal epithelia and carcinomas with ascites fluid preparations of antimelanoma antibody HMB-45. Am J Clin Pathol 95:454-459
7. Bourguignon JP, Pierard GE, Ernould C, Heinrichs C, Craen M, Rochiccioli P, Arrese JE, Franchimont C (1993) Effects of human growth hormone therapy on melanocytic naevi. Lancet I:1505-1506
8. Burnier MN, McLean IW, Gamel J (1991) Immunohistochemical evaluation of uveal melanocytic tumours. Cancer 67:1990-2001
9. Chan JKC, Tsang WYW, Pau MY, Tang MC, Pang SWP, Fletcher CDM (1993) Lymphangiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB-45 positive smooth muscle. Histopathology 22:445-455
10. Chen H, Sun GJ, Thiele B, Wolff HH (1994) The recognition of UV-irradiation melanocyte with HMB-45 monoclonal antibody. Chin Med J Engl 107: 225-229
11. Colombari R, Bonetti F, Zamboni G, Scarpa A, Marino F, Tomezzoli A, Capelii P, Menestrina F, Chilosi M, Fiore-Donati L (1988) Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. Virchows Archiv [A] 413:17-24
12. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase. J Histochem Cytochem 32:219-229
13. Fiedmann HD, Tatum AH (1991) HMB-45 positive malignant lymphoma. Arch Pathol Lab Med 115:826-830
14. Gaffey MJ, Mills SE, Zarbo RJ, Weiss LM, Gown AM (1991) Clear cell tumor of the lung. Am J Surg Pathol 15:644-653
15. Gal AA, Koss MN, Hochholzer L, Chejfec G (1991) An immunohistochemical study of benign clear cell ("sugar") tumor of the lung. Arch Pathol Lab Med 115:1034-1038
16. Gal AA, Koss MN, Hochholzer L, DeRose PB, Cohen C (1993) Pigmented pulmonary carcinoid tumor. Arch Pathol Lab Med 117:832-836
17. Garcia RL, Coltrera MD, Gown AM (1989) Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed embedded tissues. Am J Pathol 134:733
18. Gottschalk von J, Jautzke G, Schreiner C (1992) Epithelial and melanoma antigens in gliosarcoma. An immunohistochemical study. Pathol Res Pract 188:182-190
19. Gottschalk von J, Latzke G, Zimmer C (1992) Änderung des Mikromilieus und Tumorzellheterogenität - Konsequenzen für die bioptische Diagnostik. Acta histochemica 42 [Suppl]:149-154
20. Gown AM, Vogel AM, Gough DH et F, McNutt MA (1986) Monoclonal antibodies specific for melanocytic tumours distinguish subpopulations of melanocytes. Am J Pathol 123:195-203
21. Guillou L, Lamoureux E, Masse S, Costa J (1991) Alveolar soft-part sarcoma of the uterine corpus: histological, immunocytochemical and ultrastructural study of a case. Virchows Archiv [A] 418:467-471
22. Hacker GW, Springall DR, VanNoorden S, Bishop AE, Grimelius L, Polak JM (1985) The immunogold-silver staining method. Virchows Archiv [A] 406:449-461
23. Hancock C, Allen BC, Herrera GA (1991) HMB-45 detection in adenocarcinomas. Arch Pathol Lab Med 115: 886-890
24. Herrera GA, Hancock C, Allen BC (1992) Specificity of antibody HMB-45. Arch Pathol Lab Med 116:900-901
25. Ishihara M, Hashimoto K, DiGregorio FM, Setoyama M, Richards J, Pietruk T, Zarbo RJ (1992) Monoclonal anti-melanoma antibodies IKH-1 and IKH-2 which work on formalin-fixed, paraffin embedded tissues: characterization, clinical trials and comparative studies with HMB-45. J Dermatol Science 3:13-25
26. Kanitakis J, Hermier C, Chouvet B, Thivolet J (1991) Reactivity of HMB-45 monoclonal antibody with sweat-gland tumours of the skin. Acta Derm Venerol 71:426-428
27. Kapur RP, Bigler SA, Skelly M, Gown AM (1992) Anti-melanoma monoclonal antibody HMB-45 identifies an oncofetal glycoconjugate associated with immature melanosomes. J Histochem Cytochem 40:207-212
28. Kornstein MJ, Franco AP (1990) Specifity of HMB-45. Arch Pathol Lab Med 114:450
29. Kornstein MJ (1992) Specifity of antibody HMB-45. Arch Pathol Lab Med 116:901
30. Leader M, Collins M, Patel J, Henry K (1987) Vimentin: an evaluation of its role as a tumour marker. Histopathology 11:63-72
31. Leong ASY, Milios J (1989) An assessment of a melanoma-specific antibody (HMB-45) and other imnmnohistochemical markers of malignant melanoma in paraffin-embedded tissues. Surg Pathol 2:137-145
32. Osborn M, Debus E, Weber K (1984) Monoclonal antibodies specific for Vimentin. Eur J Cell Biol 34:137-143
33. Ordonez NG, Xialong J, Hickey RC (1988) Comparison of HMB-45 monoclonal antibody and S 100-Protein in the immunohistochemical diagnosis of melanoma. Am J Clin Pathol 90:385-390
34. Palazzo JP, Duray PH (1988) Congenital agminated Spitz nevi: immunoreactivity with a melanoma - associated monoclonal antibody. J Cutan Pathol 15:166-170
35. Pea M, Bonetti F, Zamboni G, Martignoni G, Riva M, Colombari R, Mombello A, Bonzanini M, Scarpa A, Ghimenton C, Donati LF (1991) Melanocyte-marker-HMB-45 is regulary expressed in angiomyolipoma of the kidney. Pathology 23:185-188
36. Rhodes AR, Albert LS, Barnhill RL, Weinstock MA (1991) Sun-induced freckles in children and young adults. Cancer 67:1990-2001
37. Schaumburg-Lever G, Metzler G, Kaiserling E (1991) Ultrastructural localization of HMB-45 binding sites. J Cutan Pathol 18:432-435
38. Sexton M, Sexton CW (1991) Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma. Arch Pathol Lab Med 115: 122-126
39. Skelton III HD, Smith KJ, Barrett TL, Lupton GP, Graham JH (1991) HMB-45 staining in benign and malignant melanocytic lesions. Am J Dermatopathol 13:543-550
40. Smoller BR, Mc Nutt NS, Hsu A (1989) HMB-45 staining of dysplastic nevi. Am J Surg Pathol 13:680-684
41. Smoller BR, Mc Nutt NS, Hsu A (1989) HMB-45 recognizes stimulated melanocytes. J Cutan Pathol 16:49-53
42. Smoller BR, Hsu A, Krueger J (1991) HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein. J Cutan Pathol 18:315-322
43. Stadler R, Garbe C (1991) Nävus-assoziierte maligne Melanome - diagnostische Sicherung und Prognose. Hautarzt 42:424-429
44. Sun J, Morton TH, Gown AM (1990) Antibody HMB-45 identifies the cells of blue nevi. Am J Surg Pathol 14:748-751
45. Taatjes DJ, Arendash-Durand B, Turkovich von M, Trainer TD (1993) HMB-45 antibody demonstrates melanosome specifity by immunoelectron microscopy. Arch Pathol LAb Med 117:264-268
46. Tallarigo C, Baldassare R, Bianchi G, Comunale L, Olivo G, Pea M, Bonetti F, Martignoni G, Zamboni G, Mobilio G (1992) Diagnostic and therapeutic problems in multicentric renal angiomyolipoma. J Urol 148:1880-1884
47. Tatum AH, Friedmann HD (1992) Specificy of antibody HMB-45. Arch Pathol Lab Med 116:900
48. Tronnier M, Schaumburg-Lever G (1986) The immunogold silver staining (IGSS) technique in dermatopathology. J Invest Dermatol 87:172 (abstr.)
49. Tronnier M, Schaumburg-Lever G, Rassner G (1989) Ein Vergleich immunhistotogischer Techniken in der Dermatopathologie. Hautarzt 40:259-265
50. Tronnier M, Wolff HH (1995) UV-irradiated melanocytic nevi may simulate melanoma in situ. Am J Dermatopathol 17:1-6
51. Tronnier M, Smolle J, Wolff HH (1995) UV-irradiation induces acute changes in melanocytic nevi. J Invest Dermatol 104:475-478
52. Tronnier M, Kämmerer R, Wolff HH (1995) Proliferative activity of keratinocytes correlates with that of the melanocytes in nevi and melanomas. Arch Dermatol Res 287:509-511
53. Tsui WMS, Yuen AKT, Ma KF, Tse CCH (1992) Hepatic angiomyolipomas with a deceptive trabecular pattern and HMB-45 reactivity. Histopathology 21:569-573
54. Unger PD, Hoffmann K, Thung SN, Pertemslides D, Wolfe D, Kaneko M (1992) HMB-45 reactivity in adrenal pheochromocytomas. Arch Pathol Lab Med 116:151-153
55. Utiger CA, Headington JT (1993) Psammomatous melanotic schwannoma. A new cutaneous marker for Carney's complex. Arch Dermatol 129:202-204
56. Walker WP, Landas SK, Bromley DM, Sturm MT (1991) Immunohistochemical distinction of classic and chondroid chordomas. Mod Pathol 4:661-666
57. Walts AE, Said JW, Shintaku IP (1988) Cytodiagnosis of malignant melanoma. Am J Clin Pathol 90:77-80
58. Wang J, Dhillon AP, Sankey EA, Wightman AK, Lewin JF, Scheuer PJ (1991) "Neuroendocrine" differentiation in primary neoplasms of the liver. J Pathol 163:61-67
59. Weeks DA, Malott RL, Arnesen M, Zuppan C, Aitken D, Mierau G (1991) Hepatic angiomyolipoma with striated granules and positivity with melanoma - specific antibody (HMB-45): a report of two cases. Ultrastruct Path 15:563-571
60. Wick MR, Stanley SJ, Swanson PE (1988) Immunohistochemical diagnosis of sinonasal melanoma, carcinoma, and neuroblastoma with monoclonal antibodies HMB-45 and anti-synaptophysin. Arch Pathol Lab Med 112:616-620
61. Wick MR, Swanson PE, Rocamora A (1988) Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin - embedded cutaneous tumours. J Cutan Pathol 15:201-207
62. Wick MR (1991) HMB-45: a clue to the biology of malignant melanoma? J Cutan Pathol 18:307-308
63. Wolff HH, Hantschke M (1993) Der dysplastische Naevus aus heutiger Sicht. In: Braun-Falco O, Plewig G, Meurer M (Hrsg) Fortschritte der praktischen Dermatologie, Bd. 13. Springer, Berlin Heidelberg New York, S 238-243
64. Wood TS, Tron VA (1991) Analysis of HMB-45 immunoreactivity in common and cellular blue nevi. J Cutan Pathol 18:261-263
65. Zimmer C, Gottschalk von J, Goebel S, Cervos-Navarro J (1991) Melanoma-associated antigens in tumours of the nervous system: an immunohistochemical study with the monoclonal antibody HMB-45. Virchows Archiv [A] 420: 121-126